Sexcord/ stromal ovarian tumors surgery: Difference between revisions
Jump to navigation
Jump to search
| Line 37: | Line 37: | ||
==Surgery== | ==Surgery== | ||
*Surgery is the mainstay of treatment for sexcord/ stromal ovarian tumors<ref name="pmid24753008">{{cite journal |vauthors=Gurumurthy M, Bryant A, Shanbhag S |title=Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent) |journal=Cochrane Database Syst Rev |volume= |issue=4 |pages=CD006912 |date=April 2014 |pmid=24753008 |doi=10.1002/14651858.CD006912.pub2 |url=}}</ref><ref name="pmid24315353">{{cite journal |vauthors=Gremeau AS, Bourdel N, Jardon K, Rabischong B, Mage G, Pouly JL, Canis M |title=Surgical management of non-epithelial ovarian malignancies: advantages and limitations of laparoscopy |journal=Eur. J. Obstet. Gynecol. Reprod. Biol. |volume=172 |issue= |pages=106–10 |date=January 2014 |pmid=24315353 |doi=10.1016/j.ejogrb.2013.10.023 |url=}}</ref> | *Surgery is the mainstay of treatment for sexcord/ stromal ovarian tumors<ref name="pmid24753008">{{cite journal |vauthors=Gurumurthy M, Bryant A, Shanbhag S |title=Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent) |journal=Cochrane Database Syst Rev |volume= |issue=4 |pages=CD006912 |date=April 2014 |pmid=24753008 |doi=10.1002/14651858.CD006912.pub2 |url=}}</ref><ref name="pmid24315353">{{cite journal |vauthors=Gremeau AS, Bourdel N, Jardon K, Rabischong B, Mage G, Pouly JL, Canis M |title=Surgical management of non-epithelial ovarian malignancies: advantages and limitations of laparoscopy |journal=Eur. J. Obstet. Gynecol. Reprod. Biol. |volume=172 |issue= |pages=106–10 |date=January 2014 |pmid=24315353 |doi=10.1016/j.ejogrb.2013.10.023 |url=}}</ref><ref name="pmid22525408">{{cite journal |vauthors=Schultz KA, Schneider DT, Pashankar F, Ross J, Frazier L |title=Management of ovarian and testicular sex cord-stromal tumors in children and adolescents |journal=J. Pediatr. Hematol. Oncol. |volume=34 Suppl 2 |issue= |pages=S55–63 |date=May 2012 |pmid=22525408 |doi=10.1097/MPH.0b013e31824e3867 |url=}}</ref> | ||
*Both benign and malignant ovarian sex cord-stromal tumors are managed surgically | *Both benign and malignant ovarian sex cord-stromal tumors are managed surgically | ||
*The schematic approach to malignant sexcord/ stromal ovarian tumors is decribed below | *The schematic approach to malignant sexcord/ stromal ovarian tumors is decribed below | ||
Revision as of 16:10, 10 April 2019
|
Sexcord/ stromal ovarian tumors Microchapters |
|
Differentiating Sexcord/ Stromal Ovarian Tumors from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Sexcord/ stromal ovarian tumors surgery On the Web |
|
American Roentgen Ray Society Images of Sexcord/ stromal ovarian tumors surgery |
|
Risk calculators and risk factors for Sexcord/ stromal ovarian tumors surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Surgical intervention is not recommended for the management of [disease name].
OR
Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
Surgery is the mainstay of treatment for [disease or malignancy].
Indications
- Surgical intervention is not recommended for the management of [disease name].
OR
- Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
- The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
Surgery
- Surgery is the mainstay of treatment for sexcord/ stromal ovarian tumors[1][2][3]
- Both benign and malignant ovarian sex cord-stromal tumors are managed surgically
- The schematic approach to malignant sexcord/ stromal ovarian tumors is decribed below
| Malignant sexcord-stromal tumors | |||||||||||||||||||||||||||||||||||||||
| Stage IA/IC: fertility desired | All others | ||||||||||||||||||||||||||||||||||||||
| Fertility sparing surgery with complete staging | Complete staging | ||||||||||||||||||||||||||||||||||||||
| Stage I, low risk | Stage I high risk(eg, ruptured stage IC or poorly differentiated stage I) or Intermediate risk(eg, heterologous elements | Stage II-IV | |||||||||||||||||||||||||||||||||||||
| Observe | Observe or consider platinum based chemotherapy | platinum based chemotherapy or radiotherapy for limited disease | |||||||||||||||||||||||||||||||||||||
| Surveillance | Surveillance | Surveillance | |||||||||||||||||||||||||||||||||||||
| If clinical relapse: Clinical trial, consider secondary cytoreductive surgery, or recurrence therapy | |||||||||||||||||||||||||||||||||||||||
Contraindications
References
- ↑ Gurumurthy M, Bryant A, Shanbhag S (April 2014). "Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent)". Cochrane Database Syst Rev (4): CD006912. doi:10.1002/14651858.CD006912.pub2. PMID 24753008.
- ↑ Gremeau AS, Bourdel N, Jardon K, Rabischong B, Mage G, Pouly JL, Canis M (January 2014). "Surgical management of non-epithelial ovarian malignancies: advantages and limitations of laparoscopy". Eur. J. Obstet. Gynecol. Reprod. Biol. 172: 106–10. doi:10.1016/j.ejogrb.2013.10.023. PMID 24315353.
- ↑ Schultz KA, Schneider DT, Pashankar F, Ross J, Frazier L (May 2012). "Management of ovarian and testicular sex cord-stromal tumors in children and adolescents". J. Pediatr. Hematol. Oncol. 34 Suppl 2: S55–63. doi:10.1097/MPH.0b013e31824e3867. PMID 22525408.